Doctor profile · Federal record

Dr. Indre Doyle, CRNP

Family Nurse Practitioner (CMS: Nurse Practitioner) · Salisbury, MD

  • NPI 1417320581
  • Accepts Medicare
  • MIPS 79.5 / 100 · 2023
  • 11 yrs in practice
  • Female
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
1415 S Division St, Suite A, Peninsula Regional Endocrinology
Salisbury, MD 218047291
(410) 572-8848
fax (410) 572-6890

Credentials & registration

NPPES · NUCC
NPI registered
November 2015 — 11 yrs on file
Year of graduation
2015 — 11 yrs since
Specialty taxonomy
363LF0000X — NUCC code
State license (1)
Maryland #AC001663

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1417320581. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
3,443
Distinct HCPCS
10
Medicare allowed
$152,522
HCPCS Description Services Patients Avg allowed
J0897 Injection, denosumab, 1 mg 2,100 31 $23
99214 Established patient office or other outpatient visit, 30-39 minutes 607 280 $110
95251 Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report 224 108 $29
99213 Established patient office or other outpatient visit, 20-29 minutes 185 157 $77
99231 Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes 98 54 $43
83036 Hemoglobin a1c level 73 67 $10
99221 Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes 38 36 $72
96372 Injection of drug or substance under skin or into muscle 35 31 $12
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes 30 29 $113
99203 New patient office or other outpatient visit, 30-44 minutes 24 24 $98

In context: peer comparison

Among 31 peers in this city , average services per provider: 219. This provider delivers 16× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$549
Transactions
20
Manufacturers
12
Payer (manufacturer) Industry Txns Amount
Amgen Inc. 2 $142.23
Abbott Laboratories 4 $83.42
Boehringer Ingelheim Pharmaceuticals, Inc. 3 $71.11
Lilly USA, LLC 2 $53.94
CeQur Corporation 1 $39.89
Novo Nordisk Inc 2 $35.46
Tandem Diabetes Care, Inc. 1 $30.33
Medtronic, Inc. 1 $24.75
BETA BIONICS, INC. 1 $18.80
Rhythm Pharmaceuticals, Inc. 1 $16.76
Xeris Pharmaceuticals, Inc. 1 $16.29
Dexcom, Inc. 1 $15.60

By nature of payment

Food and Beverage
$549

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
2,401
Patients
703
Total drug cost
$1,751,854
Drug Type Claims Patients Total cost
Metformin Hcl Generic 300 85 $3,483
Novolog Flexpen (Insulin Aspart) Brand 272 96 $427,939
Levothyroxine Sodium Generic 231 61 $3,940
Trulicity (Dulaglutide) Brand 213 38 $318,771
Ozempic (Semaglutide) Brand 207 50 $334,530
Lantus Solostar (Insulin Glargine,hum.Rec.Anlog) Brand 184 52 $126,538
Glipizide Generic 153 45 $2,257
Metformin Hcl Er (Metformin Hcl) Brand 137 42 $2,251
Basaglar Kwikpen U-100 (Insulin Glargine,hum.Rec.Anlog) Brand 121 39 $73,777
Jardiance (Empagliflozin) Brand 118 33 $141,106

Hospital affiliations

CMS Hospital Compare

Frequently asked questions

Auto-generated from federal data
What is Dr. Indre Doyle's medical specialty?
Dr. Indre Doyle practices Family Nurse Practitioner in Salisbury, MD.
Where does Dr. Indre Doyle practice?
Dr. Indre Doyle practices at 1415 S Division St, Salisbury, MD 218047291. Office phone: 4105728848.
What is Dr. Indre Doyle's NPI?
Dr. Indre Doyle's National Provider Identifier (NPI) is 1417320581, issued by NPPES.
Does Dr. Indre Doyle accept Medicare assignment?
Yes. Dr. Indre Doyle accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Indre Doyle commonly perform?
Top Medicare-reported procedures in 2023: Injection, denosumab, 1 mg (HCPCS J0897); Established patient office or other outpatient visit (HCPCS 99214); Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report (HCPCS 95251). Source: CMS Medicare Physician & Other Practitioners file.